Clinical trials
Autosomal Dominant Polycystic Kidney clinical trials
Below are recruiting autosomal dominant polycystic kidney clinical trials, each written for real people, not researchers. We’re tracking 29 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04111692Recruiting
Watching foam treatment for cysts in autosomal polycystic disease
This study follows adults with inherited kidney and/or liver cysts that are causing symptoms to see how a foam sclerotherapy procedure may help and what outcomes happen over about a year. You may be eligible if you have a few sizable, specific-type cysts and can safely attend follow-up visits.
Rochester, MinnesotaAges 18–100 - NCT03901521Enrolling by invitation
Biobank for people with autosomal dominant polycystic kidney disease
This study collects samples and health information from adults with autosomal dominant polycystic kidney disease (ADPKD) who are having their own kidney removed. It helps researchers learn more about ADPKD and its genetic changes to support future treatments.
New York, New YorkAges 18–100 - NCT02497521Recruiting
Registry for adults with ADPKD starting tolvaptan
This registry study collects information about adults with autosomal dominant polycystic kidney disease (ADPKD) who are starting or already taking tolvaptan. It may help researchers understand how tolvaptan is used in real life and what outcomes look like over time.
Müllheim, Baden-WurttembergAges 18 years+ - NCT04039061Recruiting
Study registry for people with ADPKD
This trial is a patient registry that collects information from people who have—or might have—autosomal dominant polycystic kidney disease (ADPKD). It may help researchers better understand the condition and improve future studies.
Kansas City, MissouriAges Any age - NCT02936791Recruiting
Study of early inherited kidney cysts and healthy volunteers
This observational study follows people early in autosomal dominant polycystic kidney disease (ADPKD) and also some healthy volunteers to learn how the kidneys work over time. It may help researchers understand early changes, which could guide future treatments.
Chicago, IllinoisAges 4–35
Hear when a new Autosomal Dominant Polycystic Kidney trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for autosomal dominant polycystic kidney?
- Yes. Clin2 currently lists 29 recruiting autosomal dominant polycystic kidney studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a autosomal dominant polycystic kidney trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a autosomal dominant polycystic kidney trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.